With investments, approvals, and revenues on the rise, gene editing therapy is increasingly able to address delivery and accessibility challenges.
Category: bioengineering – Page 19
An iterative engineering approach to improve prime editor delivery helped scientists correct genetic vision defects in mice.
Advances in synthetic biology are moving biopharma closer to a world where treatments can be tailored while remaining cost-effective.
The future of medicine lies in synthetic biology! In this video, you’ll learn how synthetic biology is used in healthcare and why it can help develop cancer treatments and much more.
Are you interested in furthering the field of biology or medicine? Visit uvu.edu to carve your path.
Instagram: / utah.valley.university.
Facebook: / utahvalleyuniversity.
LinkedIn: / utah-valley-university.
Twitter: / uvu.
In celebration of Earth Day and Earth Month, we’ve rounded up five sustainability discoveries made possible by advancements in synthetic biology.
Scientists are rethinking how to implement automation for biologists to reduce costs, simplify adoption, and increase reproducibility.
#bioink could be used to #Print and #Grow #Lung #Tissue.
Researchers describe their success in creating a mucus-based bioink for 3D printing lung tissue. This advancement could one day help study and treat chronic lung conditions. scitechupdates.com/mucus-based-bi…
Lung diseases kill millions of people around the world each year. Treatment options are limited, and animal models for studying these illnesses and experimental medications are inadequate. Now, writing in ACS Applied Bio Materials, researchers describe their success in creating a mucus-based bioink for 3D printing lung tissue. This advancement could one day help study and treat chronic lung conditions.
While some people with lung diseases receive transplants, donor organs remain in short supply. As an alternative, medications and other treatments can be used to manage symptoms, but no cure is available for disorders such as chronic obstructive pulmonary disease and cystic fibrosis. Researchers continue to seek better medications, often relying on testing in rodents. But these animal models may only partially capture the complexities of pulmonary diseases in humans, and they might not accurately predict the safety and efficacy of new drugs.
Meanwhile, bioengineers are exploring the production of lung tissue in the lab, either as a more accurate model to study human lungs or as a potential material to use in implants. One technique involves 3D printing structures that mimic human tissue, but designing a suitable bioink to support cell growth remains challenging. So, Ashok Raichur and colleagues set out to overcome this obstacle.
Nervous system disorders are among the leading causes of death and disability globally.
As brain research advances, how should study participants be protected? Bioethicist Saskia Hendriks has some ideas.
Innovation At The Frontiers Of Aesthetic And Regenerative Medicine — Prof. Dr. Alan Widgerow — Division Chief, Center for Tissue Engineering, UCIrvine — Chief Scientific Officer, Galderma.
Prof. Dr. Alan Widgerow, MBBCh, FCS, MMed, FACS, is Division Chief, Research, Center for Tissue Engineering (https://sites.uci.edu/ctelab/team/) and Adjunct Professor Plastic Surgery, Dept of Plastic Surgery, University of California, Irvine (https://faculty.uci.edu/profile/?facu…) and Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma (https://www.galderma.com/).
Prof. Widgerow is a plastic surgeon who ran a solo private practice in South Africa for over 20 years.
Prof. Widgerow completed his undergraduate and post-graduate studies at the University of the Witwatersrand, South Africa. He has held various positions in numerous academic and professional associations including that of President of the Association of Plastic and Reconstructive surgery of Southern Africa (APRSSA). He is author of over 190 plastic surgical related publications and 2 books. He was also the founder and medical director of 13 wound clinics in South Africa.
Prof. Widgerow relocated to Irvine California in Dec 2009 to pursue his interests in medical device innovations, cosmeceuticals and wound care, but he still plays an active role in academic medicine world-wide. In 2012 he was appointed to the Faculty of the University of California Irvine Plastic Surgery Dept as Full Adjunct Professor and Director of the Center for Tissue Engineering and in 2021 was appointed as its Division Chief of Research. He is involved in multiple projects related to adipose derived stem cell and adipose decellularized matrix, wound healing and transplantation. In 2018 he was awarded the Distinguished Faculty Mentor of the year Award by the Institute for Clinical and Translational Science, UCI.
Inventing a new, faster way to produce sustainable, self-dyed leather alternatives is a major achievement for synthetic biology and sustainable fashion. Professor Tom Ellis
Synthetic chemical dyeing is one of the most environmentally toxic processes in fashion, and black dyes – especially those used in colouring leather – are particularly harmful. The researchers at Imperial set out to use biology to solve this.